TradeOrgs
  • 🇮🇳 India
  • 🇺🇸 US
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,377.50▲ 14.60%TCS₹2,376.20▼ 3.44%HDFCBANK₹846.00▲ 18.82%ICICIBANK₹1,640.00▲ 18.75%INFY₹1,098.00▼ 2.89%HINDUNILVR₹2,052.50▲ 10.75%ITC₹299.10▲ 14.69%SBIN₹1,165.10▲ 19.66%BHARTIARTL₹2,161.70▲ 15.28%KOTAKBANK₹515.80▲ 16.62%LT₹4,209.10▲ 14.94%AXISBANK₹1,446.00▲ 16.99%ASIANPAINT₹2,608.30▲ 11.91%MARUTI₹14,011.00▲ 22.10%AAPL$342.56▲ 0.90%MSFT$484.52▼ 8.90%GOOGL$265.29▼ 22.04%AMZN$246.82▼ 6.02%NVDA$125.53▼ 42.01%META$560.84▼ 19.22%TSLA$345.82▼ 7.46%BRK-B$570.00▲ 5.59%JPM$310.53▼ 7.38%V$401.87▼ 1.16%
RELIANCE₹1,377.50▲ 14.60%TCS₹2,376.20▼ 3.44%HDFCBANK₹846.00▲ 18.82%ICICIBANK₹1,640.00▲ 18.75%INFY₹1,098.00▼ 2.89%HINDUNILVR₹2,052.50▲ 10.75%ITC₹299.10▲ 14.69%SBIN₹1,165.10▲ 19.66%BHARTIARTL₹2,161.70▲ 15.28%KOTAKBANK₹515.80▲ 16.62%LT₹4,209.10▲ 14.94%AXISBANK₹1,446.00▲ 16.99%ASIANPAINT₹2,608.30▲ 11.91%MARUTI₹14,011.00▲ 22.10%AAPL$342.56▲ 0.90%MSFT$484.52▼ 8.90%GOOGL$265.29▼ 22.04%AMZN$246.82▼ 6.02%NVDA$125.53▼ 42.01%META$560.84▼ 19.22%TSLA$345.82▼ 7.46%BRK-B$570.00▲ 5.59%JPM$310.53▼ 7.38%V$401.87▼ 1.16%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← US stocks

🇺🇸AIDX

20/20 Biolabs, Inc. - Common Stock

NASDAQ
$0.18
▼ $0.08 (-30.5%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 19 Nov 2026
H $1.50L $0.18-87.0%
$1.5$1.24$0.97$0.71$0.44$0.18$0.18
RSI (14)
Intraday · 15-minStrong sell-45RSI 44DowntrendMACD Bearishfor day-trading context — not advice

Technical signal

Neutral0
RSI (14)30
oversold 30overbought 70
Trend
Downtrend
MACD
Bullish
Bollinger
Within bands
vs 20-day
below
vs 50-day
below
vs 200-day
—
Support
$0.18
Resistance
$0.27
  • Price is below its 50-day average (medium-term weakness).
  • RSI is 30 — oversold, a level some traders read as a potential entry zone.

Signal backtest · 2026-05-15 → 2026-11-19

Strategy return
-12.2%
Buy & hold
-86.6%
Trades
2
Win rate
0%

$100,000.00 invested would be worth $87,792.21 (-12.2%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About 20/20 Biolabs, Inc.· Medical Devices

source: yahoo

20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. The company was incorporated in 2000 and is based in Gaithersburg, Maryland.

Sector
Healthcare
Industry
Medical Devices
Employees
4
Headquarters
Gaithersburg, United States
2020biolabs.com ↗

Fundamentals

No fundamental data is currently available for this listing from our data providers.

Recent news

News sentiment:▲ Positive2↑ · 0↓ · 6–
  • 20/20 BioLabs Reports Third Quarter 2026 Financial Results and Recent Business Updates— Neutral
    GlobeNewswire · 16 Nov 2026
  • REMINDER TO VOTE: 20/20 BioLabs Special Meeting of Stockholders to Be Held December 9, 2026— Neutral
    GlobeNewswire · 05 Nov 2026
  • 20/20 BioLabs to Host November 4 Investor Webinar on OneTest™ Commercial Expansion and Growth Strategy▲ Positive
    GlobeNewswire · 29 Oct 2026
  • 20/20 BioLabs to Participate in the Maxim Growth Summit 2026 in New York on October 14, 2026

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

▲ Positive
GlobeNewswire · 02 Oct 2026
  • 20/20 BioLabs to Host Investor Webinar on October 7, 2026 to Discuss FDA Advisory Committee Vote and New OneTest™ Franchise Model— Neutral
    GlobeNewswire · 29 Sept 2026
  • Profound Medical Stock And 2 Canadian AI Healthcare Stocks To Watch— Neutral
    Simply Wall St. · 06 Sept 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.